Skip to main content

Table 2 Markers and cytokines levels

From: Effects of antithrombin III (ATIII) treatment (high dose) in severe pre-eclampsia and HELLP syndrome with alterations of coagulation inhibitors and inflammatory markers: a preliminary report

 

Levels at Admission

Levels after

 

(n=7)

ATIII treatment (n=7)

IL1β (pg/mL)

7.11(3.33-7.52)

3.43*(2.11-6.06)

IL6 (pg/mL)

8.75(3.67-8.08)

4.23*(2.55-7.02)

TNFα (pg/mL)

21.2(18.8-33.6)

18.1*(11.3-19.9)

Fibronectin (μ g/ml)

592(497-701)

444*(417-490)

AT III (%)

52(38-62)

91** (78-96)

  1. IL=Interleukin; TNFα =tumor necrosis factor α ; AT III=antithrombin III; PC=Protein C. Data are presented as median concentration (range).*P<0.01 compared with levels at admission (Mann Whitney U test).**P<0.001 compared with levels at admission (Mann Whitney U test).
Back to article page

Critical Care

ISSN: 1364-8535